Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

ORPHENGESIC FORTE

ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE

Standard Dose
770MG;60MG;50MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview ORPHENGESIC FORTE is listed in Drugs@FDA under application 075141 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE Form and strength TABLET;ORAL - 770MG;60MG;50MG Sponsor GALT PHARMS Submission history Latest submission status date: 2024-11-21 00:00:00.

Structured Monograph

Clinical summary

Approval overview ORPHENGESIC FORTE is listed in Drugs@FDA under application 075141 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE Form and strength TABLET;ORAL - 770MG;60MG;50MG Sponsor GALT PHARMS Submission history Latest submission status date: 2024-11-21 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
ORPHENGESIC FORTE (ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE) | Drug Monograph | MedicHelpline